Literature DB >> 28212107

Rheb in neuronal degeneration, regeneration, and connectivity.

Veena Nambiar Potheraveedu1, Miriam Schöpel2, Raphael Stoll2, Rolf Heumann1.   

Abstract

The small GTPase Rheb was originally detected as an immediate early response protein whose expression was induced by NMDA-dependent synaptic activity in the brain. Rheb's activity is highly regulated by its GTPase activating protein (GAP), the tuberous sclerosis complex protein, which stimulates the conversion from the active, GTP-loaded into the inactive, GDP-loaded conformation. Rheb has been established as an evolutionarily conserved molecular switch protein regulating cellular growth, cell volume, cell cycle, autophagy, and amino acid uptake. The subcellular localization of Rheb and its interacting proteins critically regulate its activity and function. In stem cells, constitutive activation of Rheb enhances differentiation at the expense of self-renewal partially explaining the adverse effects of deregulated Rheb in the mammalian brain. In the context of various cellular stress conditions such as oxidative stress, ER-stress, death factor signaling, and cellular aging, Rheb activation surprisingly enhances rather than prevents cellular degeneration. This review addresses cell type- and cell state-specific function(s) of Rheb and mainly focuses on neurons and their surrounding glial cells. Mechanisms will be discussed in the context of therapy that interferes with Rheb's activity using the antibiotic rapamycin or low molecular weight compounds.

Entities:  

Keywords:  axonal regeneration; mTORC1; neurodegenerative diseases; neuronal protection; stem cells; tuberous sclerosis complex

Mesh:

Substances:

Year:  2017        PMID: 28212107     DOI: 10.1515/hsz-2016-0312

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  7 in total

1.  ATF6 Regulates Cardiac Hypertrophy by Transcriptional Induction of the mTORC1 Activator, Rheb.

Authors:  Erik A Blackwood; Christoph Hofmann; Michelle Santo Domingo; Alina S Bilal; Anup Sarakki; Winston Stauffer; Adrian Arrieta; Donna J Thuerauf; Fred W Kolkhorst; Oliver J Müller; Tobias Jakobi; Christoph Dieterich; Hugo A Katus; Shirin Doroudgar; Christopher C Glembotski
Journal:  Circ Res       Date:  2019-01-04       Impact factor: 17.367

2.  Glyceraldehyde-3-Phosphate Dehydrogenase Facilitates Macroautophagic Degradation of Mutant Huntingtin Protein Aggregates.

Authors:  Surbhi Chaudhary; Asmita Dhiman; Rahul Dilawari; Gaurav Kumar Chaubey; Sharmila Talukdar; Radheshyam Modanwal; Anil Patidar; Himanshu Malhotra; Chaaya Iyengar Raje; Manoj Raje
Journal:  Mol Neurobiol       Date:  2021-08-18       Impact factor: 5.590

3.  Known and Unexplored Post-Translational Modification Pathways in Schizophrenia.

Authors:  Bradley J Smith; Victor C Carregari
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  AKT3 Gene Transfer Promotes Anabolic Reprogramming and Photoreceptor Neuroprotection in a Pre-clinical Model of Retinitis Pigmentosa.

Authors:  Devin S McDougald; Tyler E Papp; Alexandra U Zezulin; Shangzhen Zhou; Jean Bennett
Journal:  Mol Ther       Date:  2019-04-14       Impact factor: 12.910

Review 5.  The Roles of Post-Translational Modifications on mTOR Signaling.

Authors:  Shasha Yin; Liu Liu; Wenjian Gan
Journal:  Int J Mol Sci       Date:  2021-02-11       Impact factor: 5.923

6.  miR-155-5p in Extracellular Vesicles Derived from Choroid Plexus Epithelial Cells Promotes Autophagy and Inflammation to Aggravate Ischemic Brain Injury in Mice.

Authors:  Zhang Yang; Xiaofang Shi; Zidan Gao; Lan Chu
Journal:  Oxid Med Cell Longev       Date:  2022-02-16       Impact factor: 6.543

7.  A small molecule inhibitor of Rheb selectively targets mTORC1 signaling.

Authors:  Sarah J Mahoney; Sridhar Narayan; Lisa Molz; Lauren A Berstler; Seong A Kang; George P Vlasuk; Eddine Saiah
Journal:  Nat Commun       Date:  2018-02-07       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.